LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | - | - | - | - | - | - |
1 | - | - | - | - | - | - | - | - | - | - | - |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 4.2 |
1 | 12.2 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 44.0 |
1 | 276.2 |
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#aMe12 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe22 (R) | Glu | 8 | 2.7 | 23.5% | 23.5% |
1 | MeVPLo2 (L) | ACh | 5 | 1.7 | 14.7% | 38.2% |
2 | aMe12 (L) | ACh | 3 | 1.0 | 8.8% | 47.1% |
3 | DN1a (R) | unclear | 3 | 1.0 | 8.8% | 55.9% |
instance | NT | total connections | connections /#aMe12 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | 5thsLNv_LNd6 (R) | ACh | 57 | 19.0 | 23.6% | 23.6% |
1 | aMe30 (R) | Glu | 23 | 7.7 | 9.5% | 33.1% |
2 | LoVC23 (L) | GABA | 22 | 7.3 | 9.1% | 42.1% |
3 | aMe22 (R) | Glu | 14 | 4.7 | 5.8% | 47.9% |
4 | MeVC21 (R) | Glu | 14 | 4.7 | 5.8% | 53.7% |
5 | aMe23 (R) | unclear | 11 | 3.7 | 4.5% | 58.3% |
6 | aMe4 (R) | ACh | 9 | 3.0 | 3.7% | 62.0% |
7 | l-LNv (R) | unclear | 8 | 2.7 | 3.3% | 65.3% |
8 | OA-AL2i3 (R) | OA | 8 | 2.7 | 3.3% | 68.6% |
9 | aMe1 (R) | GABA | 7 | 2.3 | 2.9% | 71.5% |
10 | aMe25 (R) | unclear | 7 | 2.3 | 2.9% | 74.4% |
11 | aMe6c (R) | Glu | 6 | 2.0 | 2.5% | 76.9% |
12 | Lat3 (R) | unclear | 5 | 1.7 | 2.1% | 78.9% |
13 | MeVPMe7 (R) | Glu | 5 | 1.7 | 2.1% | 81.0% |
14 | SLP250 (R) | unclear | 4 | 1.3 | 1.7% | 82.6% |
15 | aMe10 (R) | ACh | 3 | 1.0 | 1.2% | 83.9% |
16 | aMe12 (L) | ACh | 3 | 1.0 | 1.2% | 85.1% |
17 | aMe26 (R) | ACh | 3 | 1.0 | 1.2% | 86.4% |
18 | aMe5 (R) | ACh | 3 | 1.0 | 1.2% | 87.6% |
19 | aMe_TBD1 (R) | unclear | 3 | 1.0 | 1.2% | 88.8% |
20 | MeVC20 (R) | Glu | 3 | 1.0 | 1.2% | 90.1% |
21 | MeVPMe12 (R) | ACh | 3 | 1.0 | 1.2% | 91.3% |